Showing results (1731-1740 of 4,206) with videos related to
Sort By:
Pageof 421
Current Topics in Medicinal Chemistry|December 30, 2011
Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO)Caroline Nothdurfter, Rainer Rupprecht, Gerhard RammesCurrent Topics in Medicinal Chemistry|December 30, 2011
Geometrically constrained derivatives of indolylglyoxylamides as ligands binding the GABAA/BzR complexS Sartini, M Morelli, F Simorini, et al.Current Topics in Medicinal Chemistry|December 13, 2012
Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survivalMakoto Naoi, Wakako Maruyama, Keiko Inaba-HasegawaCurrent Topics in Medicinal Chemistry|December 13, 2012
Predicting monoamine oxidase inhibitory activity through ligand-based modelsSantiago Vilar, Giulio Ferino, Elias Quezada, et al.Current Topics in Medicinal Chemistry|January 2, 2013
Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitorsDaniela Secci, Simone Carradori, Adriana Bolasco, et al.Current Topics in Medicinal Chemistry|January 3, 2013
Neurofunctional correlates of theory of mind deficits in schizophreniaM Bosia, R Riccaboni, S PolettiCurrent Topics in Medicinal Chemistry|January 3, 2013
Neuroimaging correlates of 22q11.2 deletion syndrome: implications for schizophrenia researchE Boot, T A M J van AmelsvoortCurrent Topics in Medicinal Chemistry|January 3, 2013
Alterations of brain membranes in schizophrenia: impact of phospholipase A(2)E L Schaeffer, W F Gattaz, G P EckertCurrent Topics in Medicinal Chemistry|January 3, 2013
The concept of salience network dysfunction in schizophrenia: from neuroimaging observations to therapeutic opportunitiesL Palaniyappan, T P White, P F LiddleCurrent Topics in Medicinal Chemistry|January 3, 2013
Brain connectivity and gyrification as endophenotypes for schizophrenia: weight of the evidenceT White, I GottesmanPageof 421